NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Home » Articles posted by Vidya Sagar

All articles by Vidya Sagar

Amgen announces US roll-out of first biosimilar to Humira

US-based biotechnology company Amgen has announced the US commercialisation of Amjevita (adalimumab-atto), its biosimilar to AbbVie’s antibody therapy Humira (adalimumab). Amjevita’s active pharmaceutical ingredient (API) is an anti-TNF-α